Tested Applications
| Positive WB detected in | mouse kidney tissue, rat kidney tissue |
| Positive IHC detected in | human lymphoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11288-1-AP targets Granzyme A in WB, IHC, IF, ELISA, Blocking assay applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, chicken |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag1818 Product name: Recombinant human GZMA protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-262 aa of BC015739 Sequence: MRNSYRFLASSLSVVVSLLLIPEDVCEKIIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCNGDSGSPLLCEGVFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTIKGAV Predict reactive species |
| Full Name | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| Calculated Molecular Weight | 29 kDa |
| Observed Molecular Weight | 27-30 kDa, 50-60 kDa |
| GenBank Accession Number | BC015739 |
| Gene Symbol | Granzyme A |
| Gene ID (NCBI) | 3001 |
| RRID | AB_2114392 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P12544 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Granzyme A(GrA, a tryptase) is necessary for target cell lysis in cell-mediated immune responses. It activates mitochondrial outer membrane permeabilization- and caspase-independent cell death pathways by cleaving the mitochondrial complex I component NDUFS3after lys56. Among serine proteases GrA has an unique quaternary structure consisting of a disulphide-linked homodimer of 60kDa linked via Cys93.(PMID: 12819769) This protein has 2 isoforms produced by alternative promoter usage with the MW of 29 and 27 kDa.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for Granzyme A antibody 11288-1-AP | Download protocol |
| WB protocol for Granzyme A antibody 11288-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Granzyme A Polyclonal antibody (Cat# 11288-1-AP) has 19 citations spanning journals including Immunity, Advanced Science, Cell Reports Medicine, Cell Death & Disease, Carbohydrate Polymers, Frontiers in Immunology, Inflammation and Regeneration, and others. Research fields encompass immunology, cancer (hepatocellular, endometrial, gastric, ovarian), pyroptosis, ferroptosis, NK cell cytotoxicity, rheumatoid arthritis, inflammatory bowel disease, sepsis, GVHD, epilepsy, and avian infectious diseases. Applications include WB, IHC, IF, and blocking assays in human, mouse, and chicken models.
| Species | Application | Title |
|---|---|---|
Immunity Exosite-mediated targeting of GSDMB by dimeric granzyme A in lymphocyte pyroptotic killing | ||
Adv Sci (Weinh) PM(10) Impairs CD56(dim) NK Cell Cytotoxicity via FNBP1 Suppression to Exacerbate Rheumatoid Arthritis: Insights from Multimodal Multi-Omics. | ||
Cell Rep Med Spleen-targeted neoantigen mRNA vaccine induces ISG15(+) CD8(+) T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma. | ||
Carbohydr Polym Structural characterization and antitumor activity via immune modulation of an α-glucan from Grifola frondosa. | ||
Cell Death Dis Single-cell transcriptome profiles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identifies specific sensitive drugs | ||
Int J Biol Sci Rapamycin and Low-dose IL-2 Mediate an Immunosuppressive Microenvironment to Inhibit Benign Prostatic Hyperplasia |









